Ashvin Gandhi
Assistant Professor of Strategy
About
Ashvin Gandhi conducts his research predominantly at the intersection of industrial organization and health economics. He is particularly interested in how firm strategy interacts with health care policy and regulation. His current work asks what would happen if the United States were to regulate pharmaceutical prices to be lower than in other countries. He finds that the dominant effect of such a reference pricing policy could influence drug companies to raise prices in other countries rather than lower them in the U.S.
Topics
7 Articles
Nursing Home Industry Profits Obscured by Related-Party Transactions
Management and real estate deals to owners’ firms siphon off most profits
More Staffers: More COVID-19 Exposures and More Nursing Home Deaths
Reliance on part-timers raises headcounts and dangers to patients
Link Between Unvaccinated Staff and Nursing Home Deaths
Higher morbidity found where fewer staffers are vaccinated against COVID-19
Codifying the Nursing Home Industry’s Elusive, Alarming Turnover Rates
Payroll data allows researchers to finally build an accurate and meaningful measurement
Private Equity Boosts Nursing Home Staffing — When Compelled by Competition
But in uncompetitive markets, the financial owners cut staff
Medicare Ratings Didn’t Predict Nursing Homes’ Initial COVID-19 Vulnerability
Rate of spread in the surrounding community was a bigger indicator of risk
How Nursing Homes Selectively Admit Patients for Optimal Profits
When beds are limited, turning away the sickest and poorest boosts margins